Eight oxytocin (OT) antagonists with general structure Mpa(1)Sar(7)Arg(8), substituted at position 2 with conformationally constrained and bulky amino acids, were synthesized and pharmacologically tested. Binding affinities and selectivities of compounds for OT, and vasopressin receptor subtypes were investigated. In vitro effects of antagonists were evaluated via inhibition of OT-induced contractions of isolated guinea-pig uterus. The abilities of OT antagonists to inhibit spontaneous contractility in 24 h postpartum rat uterus were investigated. These peptides exhibited pseudoirreversible pharmacological properties, and comprise a novel group of OT antagonists for potential clinical use. Their noncompetitive pharmacological nature can be ...
Some space-constraining amino acid-containing oxytocin analogues were synthesized, of which the biol...
Vasopressin and oxytocin are synthesised in the hypothalamus and released to the blood stream via th...
benzamide, hydrochloride (SSR126768A), a new potent and se-lective, orally active oxytocin (OT) rece...
The oxytocin antagonist [Mpa1, d-Tyr(Et)2, Thr4, Orn8]-oxytocin has been successfully used for treat...
ABSTRACT We have discovered a new, potent, selective, and orally active oxytocin receptor antagonist...
AbstractNon-peptide antagonists of the oxytocin receptor (OTR) have been developed to prevent pre-te...
Oxytocin is a potent uterotonic agent administered to nearly all patients during childbirth in the U...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
Substitution of Asn5 in oxytocin (OT) or vasopressin (VP) invari-ably leads to a dramatic loss of th...
Context: Novel small molecule inhibitors of the oxytocin receptor (OTR) may have distinct pharmacol...
With a view to the aetiology and treatment of preterm labour and primary dysmenorrhoea we studied th...
Vasopressin and oxytocin seem to have pivotal roles in the pathophysiology of primary dysmenorrhoea ...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
Oxytocin and vasopressin mediate various physiological functions that are important for osmoregulati...
The affinity and specificity of an antagonist of oxytocin, [1-D(CH 2)5,Tyr(ME) 2,Thr4,Tyr-NH 29]orni...
Some space-constraining amino acid-containing oxytocin analogues were synthesized, of which the biol...
Vasopressin and oxytocin are synthesised in the hypothalamus and released to the blood stream via th...
benzamide, hydrochloride (SSR126768A), a new potent and se-lective, orally active oxytocin (OT) rece...
The oxytocin antagonist [Mpa1, d-Tyr(Et)2, Thr4, Orn8]-oxytocin has been successfully used for treat...
ABSTRACT We have discovered a new, potent, selective, and orally active oxytocin receptor antagonist...
AbstractNon-peptide antagonists of the oxytocin receptor (OTR) have been developed to prevent pre-te...
Oxytocin is a potent uterotonic agent administered to nearly all patients during childbirth in the U...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
Substitution of Asn5 in oxytocin (OT) or vasopressin (VP) invari-ably leads to a dramatic loss of th...
Context: Novel small molecule inhibitors of the oxytocin receptor (OTR) may have distinct pharmacol...
With a view to the aetiology and treatment of preterm labour and primary dysmenorrhoea we studied th...
Vasopressin and oxytocin seem to have pivotal roles in the pathophysiology of primary dysmenorrhoea ...
The neurohypophyseal nonapeptide oxytocin (OT) is the main hormone responsible for the initiation of...
Oxytocin and vasopressin mediate various physiological functions that are important for osmoregulati...
The affinity and specificity of an antagonist of oxytocin, [1-D(CH 2)5,Tyr(ME) 2,Thr4,Tyr-NH 29]orni...
Some space-constraining amino acid-containing oxytocin analogues were synthesized, of which the biol...
Vasopressin and oxytocin are synthesised in the hypothalamus and released to the blood stream via th...
benzamide, hydrochloride (SSR126768A), a new potent and se-lective, orally active oxytocin (OT) rece...